Literature DB >> 36168088

Umbilical Cord Maternal Microchimerism in Normal and Preeclampsia Pregnancies.

Raj Shree1, Stephen McCartney2, Emma Cousin2, Angel Chae2, Hilary S Gammill2, J L Nelson3,4, Sami B Kanaan3.   

Abstract

Bidirectional exchange of cells between mother and fetus establishes microchimerism (Mc). Mc can persist for decades and is associated with later-life health and disease. Greater fetal Mc is detected in the maternal compartment in preeclampsia (PE), but whether maternal Mc (MMC) in umbilical cord blood (CB) is altered in PE is unknown. We evaluated MMc in CB from normal and PE pregnancies. DNA from CB mononuclear cells following placental delivery (n = 36 PE, n = 37 controls) and maternal blood was extracted and genotyped. MMc, quantified by qPCR assays targeting maternal-specific nonshared polymorphisms in CB, was compared using logistic and negative binomial regression models. Clinically and statistically relevant confounders were included, and included the total number of cell equivalents tested, gravidity, mode of delivery, birthweight, and fetal sex. PE participants delivered at earlier gestational ages, with higher Cesarean rates, and lower infant birthweights. CB MMc detection was similar between PE and controls (52.8% vs. 51.3%, respectively, p = 0.90) and unchanged after adjustment for confounders. MMc concentration was not different between groups (mean 73.7 gEq/105 gEq in PE vs. mean 22.8 gEq/105 in controls, p = 0.56), including after controlling for confounders (p = 0.64). There was no difference in CB MMc detection or concentration between PE and normal pregnancies, despite previously noted greater fetal Mc in the maternal compartment. This suggests possible differential transfer of cells at the maternal fetal interface in PE. Phenotypic evaluation of Mc cells may uncover underlying mechanisms for differential cellular exchange between mother and fetus in PE.
© 2022. The Author(s), under exclusive licence to Society for Reproductive Investigation.

Entities:  

Keywords:  Cord blood; Maternal–fetal interface; Microchimerism; Preeclampsia

Year:  2022        PMID: 36168088     DOI: 10.1007/s43032-022-01080-0

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  33 in total

1.  Maternal CD4+ microchimerism in HIV-exposed newborns after spontaneous vaginal delivery or caesarean section.

Authors:  H Buxmann; A Reitter; S Bapistella; M Stürmer; C Königs; H Ackermann; F Louwen; P Bader; R L Schlößer; A M Willasch
Journal:  Early Hum Dev       Date:  2016-06-25       Impact factor: 2.079

2.  Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes.

Authors:  German Tapia; Georgina Mortimer; Jody Ye; Benjamin T Gillard; Saranna Chipper-Keating; Karl Mårild; Marte K Viken; Benedicte A Lie; Geir Joner; Torild Skrivarhaug; Pål R Njølstad; Ketil Størdal; Kathleen M Gillespie; Lars C Stene
Journal:  Pediatr Diabetes       Date:  2019-06-19       Impact factor: 4.866

Review 3.  Microchimerism: Defining and redefining the prepregnancy context - A review.

Authors:  H S Gammill; W E Harrington
Journal:  Placenta       Date:  2017-08-31       Impact factor: 3.481

Review 4.  The otherness of self: microchimerism in health and disease.

Authors:  J Lee Nelson
Journal:  Trends Immunol       Date:  2012-05-19       Impact factor: 16.687

5.  Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy.

Authors:  K M Adams Waldorf; H S Gammill; J Lucas; T M Aydelotte; W M Leisenring; N C Lambert; J L Nelson
Journal:  Placenta       Date:  2010-05-31       Impact factor: 3.481

6.  Maternal Microchimerism in Cord Blood and Risk of Celiac Disease in Childhood.

Authors:  German Tapia; Georgina Mortimer; Jody Ye; Karl Mårild; Saranna Chipper-Keating; Benjamin T Gillard; Marte K Viken; Benedicte A Lie; Lars C Stene; Kathleen M Gillespie; Ketil Størdal
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-09       Impact factor: 2.839

7.  Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.

Authors:  Jeff E Mold; Jakob Michaëlsson; Trevor D Burt; Marcus O Muench; Karen P Beckerman; Michael P Busch; Tzong-Hae Lee; Douglas F Nixon; Joseph M McCune
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

8.  Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice.

Authors:  Partha Dutta; Melanie Molitor-Dart; Joseph L Bobadilla; Drew A Roenneburg; Zhen Yan; Jose R Torrealba; William J Burlingham
Journal:  Blood       Date:  2009-08-21       Impact factor: 22.113

9.  Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins.

Authors:  Chie-Pein Chen; Ming-Yi Lee; Jian-Pei Huang; John D Aplin; Yi-Hsin Wu; Cing-Siang Hu; Pei-Chun Chen; Hung Li; Shiaw-Min Hwang; Shu-Hsiang Liu; Yuh-Cheng Yang
Journal:  Stem Cells       Date:  2007-11-01       Impact factor: 6.277

10.  Determining the extent of maternal-foetal chimerism in cord blood.

Authors:  Rianne Opstelten; Manon C Slot; Neubury M Lardy; Arjan C Lankester; Arend Mulder; Frans H J Claas; Jon J van Rood; Derk Amsen
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.